市場調査レポート
商品コード
1428281

細胞治療・遺伝子治療サプライチェーン/ロジスティクスの世界市場レポート 2024

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
細胞治療・遺伝子治療サプライチェーン/ロジスティクスの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

細胞治療・遺伝子治療サプライチェーン/ロジスティクスの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.2%の年間複合成長率(CAGR)で21億5,000万米ドルに成長すると予想されます。予測期間で予想される成長は、個別化医療の拡大、無細胞療法の進歩、慢性疾患の有病率の増加、世界の細胞療法製造市場の成長、サプライチェーン要件の効果的な利用に関連している可能性があります。予測期間中に予想される主な動向には、研究開発支出の増加、先進技術の導入、アクセシビリティを高めるための有利な取り組みやプログラム、細胞および遺伝子治療会社、サプライチェーンプロバイダー、ロジスティクス間のパートナーシップや協力の形成、さまざまな段階の患者識別をサポートするカスタマイズ可能なサービスを提供する企業などが含まれます。

細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場の成長は、細胞治療および遺伝子治療の需要の高まりによって促進されています。これらの革新的な医療は、細胞や遺伝子を改変して疾患に対処するもので、これまで治療できなかった症状に画期的な進歩をもたらす可能性があります。これらの治療法では、温度管理を含む適切な保管条件を確保することが極めて重要であり、サプライチェーンと物流サービスは治療薬の調達、流通、保管において重要な役割を果たします。たとえば、調査者向けの米国拠点のオンラインリソースであるCell &Geneの報告によると、2022年 2月、細胞および遺伝子治療への民間投資は680億米ドルに達し、承認された治療法の数は2021年に10%増加しました。したがって、細胞および遺伝子治療に対するニーズの高まりが、細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場の原動力となっています。

細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場の予想される成長は、個別化医療に対する需要の高まりによってさらに支えられています。個別化医療には、医療上の決定、介入、薬物療法を個々の患者に合わせて調整することが含まれ、細胞治療・遺伝子治療サプライチェーン/ロジスティクスサービスは、これらの精密医薬品を安全かつ効果的に届ける上で重要な役割を果たします。サプライチェーン全体の整合性を維持するために、温度監視が組み込まれています。米国に本拠を置く健康関連報道会社STATの報道によると、2022年10月時点で遺伝子検査製品は7万5000以上、個別化医薬品は300種あり、個別化医療ソリューションへの需要の高まりが浮き彫りとなっています。したがって、個別化医療に対する需要の高まりが、細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場の成長の主な原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018~2023年
  • 市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場、ソフトウェアソリューションの種類別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 細胞オーケストレーションプラットフォーム
  • エンタープライズ製造システム
  • 在庫管理システム
  • 研究室情報管理システム
  • 物流管理システム
  • 患者管理システム
  • 品質管理システム
  • トラック・トレースシステム
  • 世界の細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場、展開モード別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • クラウドベースソリューション
  • オンプレミスソリューション
  • 世界の細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場、コンポーネント別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 極低温輸送業者
  • 極低温貯蔵フリーザー
  • 超低温フリーザー
  • コールドチェーン管理システム
  • 出荷
  • 記憶媒体
  • 極低温パックアウトキット
  • その他
  • 世界の細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場、アプリケーション分野別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ドナーの適格性評価
  • サンプルコレクション
  • 製造
  • ロジスティクス
  • 患者の認証
  • 治療のフォローアップ
  • 世界の細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • バイオバンク
  • 細胞治療研究室
  • 病院
  • 研究機関
  • 商業組織

第7章 地域および国の分析

  • 世界の細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場の競合情勢
  • 細胞治療・遺伝子治療サプライチェーン/ロジスティクス市場の企業プロファイル
    • AmerisourceBergen Corporation
    • United Parcel Service
    • Thermo Fisher Scientific Inc.
    • Avantor Sciences
    • Lonza Group AG

第31章 その他の大手および革新的な企業

  • Arvato Group
  • Catalent Inc.
  • Charles River Laboratories International
  • Parexel International Corporation
  • Cytiva
  • Almac Group
  • World Courier
  • Sharp Packaging Services
  • PCI Pharma Services
  • Cryoport Inc.
  • Brooks Life Sciences
  • BioLife Solutions Inc.
  • Biocair Inc.
  • QuickSTAT
  • Clarkston Consulting Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14125

Cell and gene therapy supply chain and logistics encompass the systematic coordination and management of materials, information, and resources essential for the development, production, and distribution of cell and gene therapies, ensuring their safe and effective administration to patients. These services deliver advanced treatments to patients, upholding the highest standards of safety and efficacy throughout the entire supply chain.

Various software solutions play crucial roles in these processes, including cell orchestration platforms, enterprise manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems. A cell orchestration platform is a software or technological platform facilitating the coordination, management, and integration of diverse processes related to cell therapy development, manufacturing, and delivery. It streamlines and automates tasks associated with cell sourcing, manufacturing, quality control, logistics, patient tracking, and data management. These platforms are deployed as cloud-based or on-premises solutions and are utilized in cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment, storage medium, cryogenic packout kits, and other components. Applications include donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up. End-users encompass biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

The cell and gene therapy supply chain/logistics research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy supply chain/logistics market statistics, including the cell and gene therapy supply chain/logistics industry's global market size, regional shares, competitors with a cell and gene therapy supply chain/logistics market share, detailed cell and gene therapy supply chain/logistics market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy supply chain/logistics industry. This cell and gene therapy supply chain/logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.4 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historical period can be ascribed to the increasing prevalence of chronic diseases, the effective management of supply chain requirements, heightened focus on maintaining drug integrity, the evolution of regulatory frameworks, and a growing emphasis on risk mitigation and compliance.

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period can be associated with the expansion of personalized medicine, the advancement of cell-free therapies, the increasing prevalence of chronic diseases, the growth of the global cell therapy manufacturing market, and the effective utilization of supply chain requirements. Key trends expected in the forecast period encompass a rise in research and development expenditure, the adoption of advanced technologies, favorable initiatives and programs to enhance accessibility, and the formation of partnerships and collaborations among cell and gene therapy companies, supply chain providers, and logistics companies, offering customizable services to support various stages of patient identification

The growth of the cell and gene therapy supply chain/logistics market is fueled by the rising demand for cell and gene therapies. These innovative medical treatments, which involve modifying cells or genes to address diseases, present potential breakthroughs for previously untreatable conditions. Ensuring the proper storage conditions, including temperature control, is crucial for these therapies, and supply chain and logistics services play a vital role in sourcing, distributing, and storing them. For instance, in February 2022, private investment in cell and gene therapy reached $68 billion, and the number of approved therapies saw a 10% growth in 2021, as reported by Cell & Gene, a US-based online resource for research scholars. Hence, the increasing need for cell and gene therapies is a driving force in the cell and gene therapy supply chain/logistics market.

The anticipated growth of the cell and gene therapy supply chain/logistics market is further supported by the increasing demand for personalized medicine. Personalized medicine involves tailoring medical decisions, interventions, and drug therapies to individual patients, and the supply chain/logistics services for cell and gene therapies play a critical role in delivering these precision medicines safely and effectively. Temperature monitoring is incorporated to maintain integrity throughout the supply chain. As of October 2022, there were over 75,000 genetic testing products and 300 personalized medicines, highlighting the growing demand for personalized medical solutions, according to reports published by STAT, a US-based health-oriented news company. Therefore, the rising demand for personalized medicine is a key driver of the growth in the cell and gene therapy supply chain/logistics market.

The adoption of modern technology platforms stands out as a key trend in the cell and gene therapy supply chain/logistics markets. Major companies within this sector are actively developing advanced technology platforms to enhance their position in the market. For instance, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company specializing in cell and gene therapy supply chain logistics, introduced the Cell and Gene Therapy (CGT) Integration Hub. This innovative hub, powered by AmerisourceBergen's customer relationship management (CRM) system, can seamlessly integrate into the biopharma platform, enabling improved monitoring of the development and delivery processes for cell and gene therapies.

Leading companies in the cell and gene therapy supply chain/logistics sector are concentrating on introducing next-generation solutions, including off-the-shelf cell orchestration platforms. These platforms offer streamlined supply chain management, pre-designed modules, industry-proven processes, rapid deployment, and integration capabilities. For example, in January 2022, TrakCel Limited, a UK-based software company, launched OCELLOS Lite, a pre-designed, modular, and validated solution for managing the supply chain and logistics of cell and gene therapies. OCELLOS Lite facilitates supply chain process management from clinical development phases to commercialization and boasts quick deployment, making it one of the most straightforward and rapid solutions.

In April 2022, Cryoport Systems LLC, a US-based provider of temperature-controlled logistics services, acquired Cell&Co BioServices for $6.2 million. This strategic acquisition enabled Cryoport to expand its global supply chain network and better cater to the needs of the regenerative medicine industry. Cell&Co BioServices, based in France, is a supply chain management services provider for biological, pharmaceutical, and clinical samples throughout their life cycle.

Major companies operating in the cell and gene therapy supply chain/logistics market report are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2023. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell and gene therapy supply chain/logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cell and gene therapy supply chain and logistics market includes revenues earned by entities by providing sourcing and collection, quality testing, distribution, and transportation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell and gene therapy supply chain/logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy supply chain/logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy supply chain/logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type Of Software Solution: Cell Orchestration Platform; Enterprise Manufacturing System; Inventory Management System; Laboratory Information Management System; Logistics Management System; Patient Management System; Quality Management System; Tracking And Tracing System
  • 2) By Mode Of Deployment: Cloud-Based Solution; On-Premises Solution
  • 3) By Component: Cryogenic Shippers; Cryogenic Storage Freezers; Ultra-Low Freezers; Cold Chain Management Systems; Shipment; Storage Medium; Cryogenic Packout Kits; Other Components
  • 4) By Application Area: Donor Eligibility Assessment; Sample Collection; Manufacturing; Logistics; Patient Verification; Treatment Follow-Up
  • 5) By End User: Biobank; Cell Therapy Lab; Hospital; Research Institute; Commercial Organization
  • Companies Mentioned: AmerisourceBergen Corporation; United Parcel Service; Thermo Fisher Scientific Inc.; Avantor Sciences; Lonza Group AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics

3. Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies

4. Cell And Gene Therapy Supply Chain/Logistics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell And Gene Therapy Supply Chain/Logistics Market Size and Growth

  • 5.1. Global Cell And Gene Therapy Supply Chain/Logistics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

  • 6.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Orchestration Platform
  • Enterprise Manufacturing System
  • Inventory Management System
  • Laboratory Information Management System
  • Logistics Management System
  • Patient Management System
  • Quality Management System
  • Tracking And Tracing System
  • 6.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cloud-Based Solution
  • On-Premises Solution
  • 6.3. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cryogenic Shippers
  • Cryogenic Storage Freezers
  • Ultra-Low Freezers
  • Cold Chain Management Systems
  • Shipment
  • Storage Medium
  • Cryogenic Packout Kits
  • Other Components
  • 6.4. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Donor Eligibility Assessment
  • Sample Collection
  • Manufacturing
  • Logistics
  • Patient Verification
  • Treatment Follow-Up
  • 6.5. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
  • Commercial Organization

7. Cell And Gene Therapy Supply Chain/Logistics Market Regional And Country Analysis

  • 7.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market

  • 8.1. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell And Gene Therapy Supply Chain/Logistics Market

  • 9.1. China Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 9.2. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell And Gene Therapy Supply Chain/Logistics Market

  • 10.1. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell And Gene Therapy Supply Chain/Logistics Market

  • 11.1. Japan Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 11.2. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell And Gene Therapy Supply Chain/Logistics Market

  • 12.1. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market

  • 13.1. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell And Gene Therapy Supply Chain/Logistics Market

  • 14.1. South Korea Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 14.2. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market

  • 15.1. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 15.2. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell And Gene Therapy Supply Chain/Logistics Market

  • 16.1. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell And Gene Therapy Supply Chain/Logistics Market

  • 17.1. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell And Gene Therapy Supply Chain/Logistics Market

  • 18.1. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell And Gene Therapy Supply Chain/Logistics Market

  • 19.1. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell And Gene Therapy Supply Chain/Logistics Market

  • 20.1. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market

  • 21.1. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 21.2. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell And Gene Therapy Supply Chain/Logistics Market

  • 22.1. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell And Gene Therapy Supply Chain/Logistics Market

  • 23.1. North America Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 23.2. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell And Gene Therapy Supply Chain/Logistics Market

  • 24.1. USA Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 24.2. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell And Gene Therapy Supply Chain/Logistics Market

  • 25.1. Canada Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 25.2. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell And Gene Therapy Supply Chain/Logistics Market

  • 26.1. South America Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 26.2. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell And Gene Therapy Supply Chain/Logistics Market

  • 27.1. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell And Gene Therapy Supply Chain/Logistics Market

  • 28.1. Middle East Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 28.2. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell And Gene Therapy Supply Chain/Logistics Market

  • 29.1. Africa Cell And Gene Therapy Supply Chain/Logistics Market Overview
  • 29.2. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Company Profiles

  • 30.1. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape
  • 30.2. Cell And Gene Therapy Supply Chain/Logistics Market Company Profiles
    • 30.2.1. AmerisourceBergen Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. United Parcel Service
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Avantor Sciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Lonza Group AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies

  • 31.1. Arvato Group
  • 31.2. Catalent Inc.
  • 31.3. Charles River Laboratories International
  • 31.4. Parexel International Corporation
  • 31.5. Cytiva
  • 31.6. Almac Group
  • 31.7. World Courier
  • 31.8. Sharp Packaging Services
  • 31.9. PCI Pharma Services
  • 31.10. Cryoport Inc.
  • 31.11. Brooks Life Sciences
  • 31.12. BioLife Solutions Inc.
  • 31.13. Biocair Inc.
  • 31.14. QuickSTAT
  • 31.15. Clarkston Consulting Inc.

32. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking

33. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market

35. Cell And Gene Therapy Supply Chain/Logistics Market Future Outlook and Potential Analysis

  • 35.1 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer